Teprotumumab: Interpreting the Clinical Trials in the Context of Thyroid Eye Disease Pathogenesis and Current Therapies. Winn BJ, Kersten RC. Ophthalmology 2021;128:1627-1651.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Winn BJ, Kersten RC. Teprotumumab: Interpreting the Clinical Trials in the Context of Thyroid Eye Disease Pathogenesis and Current Therapies. Ophthalmology 2021;128:1627-1651.
PMID: 33930408